FINANCIAL NEWS

ASX Winners And Losers Of Today – 31-08-26

The table inside ranks the 20 biggest percentage winners and losers among stocks in the ASX300 at the end of each trading day

6:35 PM


FNArena Corporate Results Monitor – 31-08-2026

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

2:43 PM


Chemist Warehouse A Winner For Sigma Healthcare

Sigma Healthcare’s FY26 result underscored the value of last year’s merger with the Chemist Warehouse pharmacy chain

1:31 PM


Australian Listed Real Estate Tables – 31-08-2026

FNArena provides a weekly update of Australian listed real estate trusts (REIT) and property developers, current pricing yield and valuation data

10:45 AM


Australian Broker Call *Extra* Edition – Aug 31, 2026

Extra Edition of the Broker Call Report

10:30 AM


Macquarie rates DDR as Outperform

Macquarie assesses its upgrade going into the first half results for Dicker Data was well founded with turnover growth strong. Relative to the January-April update, gross profit increased to 9.8% in the first half, implying 10.4% across May-June. AI sales also accelerated.

The broker retains conservative assumptions for 2026, forecasting 34% pre-tax profit growth, slowing to 7% in 2027. On the positive side, AI deals and a return to supply in NZ are countered by negative catalysts such as rate increases and the emergence of hardware supply constraints.

Outperform rating. Target is raised to $16.70 from $12.85.

Bell Potter rates IRI as Downgrade to Hold from Buy

Integrated Research's FY26 result was better than Bell Potter expected, with revenue down -16% y/y but 1% ahead of forecast and towards the top end of guidance.

The EBITDA loss of -$2.1m was also better than the broker's -$3.1m forecast, while an unexpected 3c final dividend and 2c special dividend provided the major positive surprise.

The analyst observes visibility remains limited with the FY27 renewals book weighted to 2H27 and management continuing to invest in new products and product-led growth, which is expected to weigh on near-term profitability.

FY27/FY28 EBITDA forecasts are lowered by -7%/-29%, although the broker expects management to return to positive EBITDA and NPAT in both periods.

Bell Potter downgrades to Hold from Buy and lowers its target price to $0.36 from $0.38.

Citi rates NXT as Buy

In a follow-up to initial research on NextDC's FY26 results last week, Citi highlights bullish management commentary on the demand pipeline. The S4 data centre is expected to be sold out in FY27, with further large contracts dependent on development approvals.

The broker views plans to shorten construction times positively, particularly as build-to-suit developments have only recently become a greater focus.

While operational results were solid, Citi believes a re-rating will require greater clarity on the future funding structure, particularly for hyperscale developments.

Separately, Citi sees Nvidia reportedly pausing revenue-sharing deals with neoclouds as broadly neutral for NextDC.

Neoclouds represent only a small portion of NextDC's contracted order book and do not appear to comprise a significant part of the pipeline, the broker observes.

Target $19.10. Buy.

First take: Citi highlights NextDC's FY26 underlying EBITDA of $248m, up 15% y/y, was 4% ahead of both the broker's forecast and consensus, primarily due to stronger-than-expected net revenue, while operating costs were slightly better than forecast.

The underlying NPAT loss of -$22m was also substantially better than Citi's -$103m estimate, helped by a tax benefit and lower net finance costs.

Click here to see full report market arrow icon

ANALYSIS & DATA

FNARENA'S MARKET CONSENSUS FORECASTS

To display the stock analysis for a company please enter the company code:

ANZ | ANZ GROUP HOLDINGS LIMITED

Abbreviated format - see the full version here


LAST PRICECHANGE +/-CHANGE %VOLUME

$36.73

28 Aug
2026

market green arrow 0.270

OPEN

$36.42

market green arrow 0.74%

HIGH

$36.83

2,388,464

LOW

$36.32

TARGET
$35.630-3.0% downside
Franking for last dividend paid out: 75%
FNARENA'S MARKET CONSENSUS FORECASTS
ANZ: 1
TitleFY24
Actual
FY25
Actual
FY26
Forecast
FY27
Forecast
EPS (cps)xxx 198.2 247.3xxx
DPS (cps)xxx 166.0 166.7xxx
EPS Growthxxx- 9.1% 24.8%xxx
DPS Growthxxx 0.0% 0.4%xxx
PE RatioxxxN/A 15.0xxx
Dividend YieldxxxN/A 4.5%xxx
Div Pay Ratio(%)xxx 83.8% 67.4%xxx

FOLLOW US ON SOCIAL MEDIA

9.2K Followers
26.9K Posts
@Filapek
Rudi Filapek-Vandyck@Filapek
2h
Moelis on Kingsgate Consolidated $KCN: "The most likely element of this result to catch people's attention will be the dividend. "As the gold price rebounds (over the last 4-6 weeks), companies like KCN without any obvious growth plans and a solid balance sheet may look to use
@Filapek
Rudi Filapek-Vandyck@Filapek
2h
Citi on Austal $ASB: "FY26 revenue growth of 11% to $2.0 billion (-8% below VA Consensus), but profitability deteriorated materially, with a net loss of -$53.6 million versus a profit in the prior period. "FY26 EBIT of -$125 million was below what the company pre-reported on
@Filapek
Rudi Filapek-Vandyck@Filapek
3h
Moelis on Black Cat Syndicate $BC8: "While we anticipated a clunky result, both the revenue and underlying NPAT were broadly as expected. "The activities of the business through FY26 involved significant toll treatment at Lakewood, with various customers on different commercial
@Filapek
Rudi Filapek-Vandyck@Filapek
3h
RBC Capital on Monash IVF Group $MVF: "MVF delivered a FY26 result that reflects a challenging fiscal year for the business. "The company missed consensus (-12%), RBCe (-8%) and their own guidance (-8% at the midpoint) for underlying NPAT but includes the $1.4m impact of the
@Filapek
Rudi Filapek-Vandyck@Filapek
4h
Succinct observation by Ed Yardeni: "The AI-linked markets that led all year are leading again. "The laggards are markets with domestic problems, not those exposed to the global business cycle."#equities#investing#XJO#stocks
@Filapek
Rudi Filapek-Vandyck@Filapek
2d
How do we summarise the tail end of the August results season?#stocks#XJO@FNArena#equities#investing Answer: https://t.co/jg0CQrVuso
Tweet media
@Filapek
Rudi Filapek-Vandyck@Filapek
2d
Not unexpected, as this is traditionally always the case, the tail end of reporting season sees corporate results trending towards more misses than beats.https://t.co/pdGbTzmwWS#XJO#stocksinfocus@FNArena#equities#investing
@Filapek
Rudi Filapek-Vandyck@Filapek
3d
Jarden on Dicker Data Limited $DDR: "Rating: Overweight | Target Price: A$10.60 "•1H26 NPAT beat consensus by 15%, driven primarily by gross margin expansion to 9.8% (vs. 9.4% expected) and revenue growth of 14% y/y (1% ahead of consensus) "•CY26 PBT guidance of $162-165m
@Filapek
Rudi Filapek-Vandyck@Filapek
3d
Jarden on PEXA Group $PXA: "Rating: Underweight | Target Price: A$9.20 "•FY26 result showed exchange volumes weakening significantly, with growth slowing to +2% y/y from +7% in 3Q26, and July 2026 down -15% y/y. "•FY27E guidance materially below expectations: revenue
@Filapek
Rudi Filapek-Vandyck@Filapek
3d
Barrenjoey on Pexa Group $PXA: ": Solid FY26 result with uEBITDA and NPATA 2% and 8% ahead respectively, FCF materially better. "FY27 guidance acknowledges material uncertainty around the Australian housing market, including recent tax changes and PXA has provided transfer
FIND FNARENA ON

DAILY FINANCIAL NEWS

FNArena Corporate Results Monitor – 31-08-2026

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

2:43 PM - Australia


Sigma Healthcare’s FY26 result underscored the value of last year’s merger with the Chemist Warehouse pharmacy chain

1:31 PM - Australia


Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements

Aug 29 2026 - Australia


FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

Aug 28 2026 - Australia


FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

Aug 27 2026 - Australia


Excerpt from The AI Instinct: The Future of AI and Human Decision-Making by Rana Gujral

Aug 27 2026 - Book Reviews


rudi fnarena picture

RUDI'S VIEWS

Rudi’s View: August Delivers Soft Guidance, Higher Dividends

A closer look beneath the bonnet of corporate results and share price moves in busy August season

Aug 26 2026

DAILY MARKET REPORTS

ASX Winners And Losers Of Today – 31-08-26

The table inside ranks the 20 biggest percentage winners and losers among stocks in the ASX300 at the end of each trading day

6:35 PM


Australian Broker Call *Extra* Edition – Aug 31, 2026

Extra Edition of the Broker Call Report

10:30 AM


The Monday Report – 31 August 2026

Wrap of events affecting the market on Friday night and the weekend and a preview of the week ahead

8:34 AM


Today’s Financial Calendar – 31-08-2026

Significant Scheduled Events For 31 August, 2026

8:15 AM


ASX Winners And Losers Of Today – 28-08-26

The table inside ranks the 20 biggest percentage winners and losers among stocks in the ASX300 at the end of each trading day

Aug 28 2026


Australian Broker Call *Extra* Edition – Aug 28, 2026

Extra Edition of the Broker Call Report

Aug 28 2026


The Overnight Report: Software Boosts Tech Rally

A global perspective on what happened overnight

Aug 28 2026


WEEKLY REPORTS

Australian Listed Real Estate Tables – 31-08-2026

FNArena provides a weekly update of Australian listed real estate trusts (REIT) and property developers, current pricing yield and valuation data

10:45 AM

Weekly Ratings, Targets, Forecast Changes – 28-08-26

Weekly update on stockbroker recommendation, target price, and earnings forecast changes

10:00 AM

Next Week At A Glance – 31 Aug – 4 Sep 2026

A brief look at important company events and economic data releases next week

Aug 28 2026


In Case You Missed It – BC Extra Upgrades & Downgrades – 28-08-26

A summary of the highlights from Broker Call Extra updates throughout the week past

Aug 28 2026

Weekly Top Ten News Stories – 28 August 2026

Our top ten news stories from 20 August 2026 to 27 August 2026

Aug 28 2026

In Brief: Nuix, Abacus Group & NetWealth Group

This week’s In Brief focuses on three turnaround stories: Nuix, Abacus as management restructures its assets, and Netwealth, viewed as structurally sound but cyclically impaired

Aug 28 2026


The Short Report – 27 Aug 2026

FNArena’s weekly update on short positions in the Australian share market

Aug 27 2026

Weekly Update On LICs & LITs – 25-Aug-2026

Weekly update of Listed Investment Companies (LICs) & Listed Investment Trusts (LITs) on the ASX

Aug 25 2026

Uranium Week: Price Momentum, Results & BHP

As indicated by TradeTech a couple of weeks back, the U308 spot price was showing signs of breaking out, a move confirmed this week as Kazatomprom announced further delays to its sulphuric acid plant

Aug 25 2026


9.2K Followers
26.9K Posts
@Filapek
Rudi Filapek-Vandyck @Filapek
12h
Moelis on Kingsgate Consolidated $KCN: "The most likely element of this result to catch people's attention will be the dividend. "As the gold price rebounds (over the last 4-6 weeks), companies like KCN without any obvious growth plans and a solid balance sheet may look to use
@Filapek
Rudi Filapek-Vandyck @Filapek
13h
Citi on Austal $ASB: "FY26 revenue growth of 11% to $2.0 billion (-8% below VA Consensus), but profitability deteriorated materially, with a net loss of -$53.6 million versus a profit in the prior period. "FY26 EBIT of -$125 million was below what the company pre-reported on
@Filapek
Rudi Filapek-Vandyck @Filapek
13h
Moelis on Black Cat Syndicate $BC8: "While we anticipated a clunky result, both the revenue and underlying NPAT were broadly as expected. "The activities of the business through FY26 involved significant toll treatment at Lakewood, with various customers on different commercial
@Filapek
Rudi Filapek-Vandyck @Filapek
13h
RBC Capital on Monash IVF Group $MVF: "MVF delivered a FY26 result that reflects a challenging fiscal year for the business. "The company missed consensus (-12%), RBCe (-8%) and their own guidance (-8% at the midpoint) for underlying NPAT but includes the $1.4m impact of the
@Filapek
Rudi Filapek-Vandyck @Filapek
14h
Succinct observation by Ed Yardeni: "The AI-linked markets that led all year are leading again. "The laggards are markets with domestic problems, not those exposed to the global business cycle." #equities #investing #XJO #stocks
@Filapek
Rudi Filapek-Vandyck @Filapek
3d
How do we summarise the tail end of the August results season? #stocks #XJO @FNArena #equities #investing Answer: https://t.co/jg0CQrVuso
Tweet media
@Filapek
Rudi Filapek-Vandyck @Filapek
3d
Not unexpected, as this is traditionally always the case, the tail end of reporting season sees corporate results trending towards more misses than beats. https://t.co/pdGbTzmwWS #XJO #stocksinfocus @FNArena #equities #investing
@Filapek
Rudi Filapek-Vandyck @Filapek
3d
Jarden on Dicker Data Limited $DDR: "Rating: Overweight | Target Price: A$10.60 "•1H26 NPAT beat consensus by 15%, driven primarily by gross margin expansion to 9.8% (vs. 9.4% expected) and revenue growth of 14% y/y (1% ahead of consensus) "•CY26 PBT guidance of $162-165m
@Filapek
Rudi Filapek-Vandyck @Filapek
3d
Jarden on PEXA Group $PXA: "Rating: Underweight | Target Price: A$9.20 "•FY26 result showed exchange volumes weakening significantly, with growth slowing to +2% y/y from +7% in 3Q26, and July 2026 down -15% y/y. "•FY27E guidance materially below expectations: revenue
@Filapek
Rudi Filapek-Vandyck @Filapek
3d
Barrenjoey on Pexa Group $PXA: ": Solid FY26 result with uEBITDA and NPATA 2% and 8% ahead respectively, FCF materially better. "FY27 guidance acknowledges material uncertainty around the Australian housing market, including recent tax changes and PXA has provided transfer
FIND FNARENA ON

THE MARKETS

    Click item/line to change chart

  • Australia

    31 August 2026   Updated : 20:12   AEDT

    SPI Overnight

    9009.00

    -36.00

    -0.40%

    NZ50

    13917.300

    +149.120

    1.080%

    All Ordinaries

    9271.40

    -22.90

    -0.25%

    S&P ASX 200

    9076.00

    -16.30

    -0.18%

    S&P ASX 300

    9004.40

    -18.30

    -0.20%

    Communication Services

    1594.10

    +12.40

    0.78%

    Consumer Discretionary

    3702.50

    -13.70

    -0.37%

    Consumer Staples

    13396.80

    +120.50

    0.91%

    Energy

    11015.50

    +59.00

    0.54%

    Financials

    9288.70

    +104.70

    1.14%

    Health Care

    31624.50

    -193.20

    -0.61%

    Industrials

    8189.10

    +31.30

    0.38%

    Info Technology

    1881.30

    -26.60

    -1.39%

    Materials

    25979.10

    -535.30

    -2.02%

    Real Estate

    3382.10

    +8.20

    0.24%

    Utilities

    10258.70

    +7.20

    0.07%

    A-REITs

    1573.70

    +2.80

    0.18%

    All Technology Index

    3071.50

    -31.10

    -1.00%

    Banks

    3899.30

    +57.60

    1.50%

    Gold Index

    19530.30

    -884.90

    -4.33%

    Metals & Mining

    8972.00

    -196.50

    -2.14%

    Click item/line to change chart

  • Australasia

    31 August 2026   Updated : 20:12   AEDT

    AUD/USD

    0.7162

    0.00

    -0.06%

    AUD/NZD

    1.2105

    0.00

    -0.05%

    NZD/USD

    0.5917

    0.00

    -0.49%

    AUD/JPY

    114.41

    -0.21

    -0.18%

    SGD/AUD

    1.10

    -0.01

    -0.79%

    AUD/EUR

    0.6174

    0.00

    -0.19%

    AUD/GBP

    0.5288

    0.00

    -0.26%

    AUDCAD

    0.9947

    0.00

    -0.20%

  • World

    31 August 2026   Updated : 20:12   AEDT

    CAD/USD

    0.7201

    +0.00

    0.18%

    EUR/JPY

    185.32

    -0.14

    -0.07%

    EUR/USD

    1.1601

    +0.00

    0.16%

    GBP/USD

    1.3545

    0.00

    -0.01%

    USD/JPY

    159.74

    -0.35

    -0.22%

    Click item/line to change chart

  • World

    31 August 2026   Updated : 20:12   AEDT

    FTSE100

    10824.26

    +31.72

    0.29%

    DAX30

    26386.12

    -183.87

    -0.69%

    Hang Seng

    25566.99

    -17.80

    -0.07%

    Nikkei 225

    66311.93

    -93.63

    -0.14%

    NZ50

    13917.300

    +149.120

    1.080%

    DJIA

    53559.99

    -9.45

    -0.02%

    S&P500

    7711.76

    -19.23

    -0.25%

    Nasdaq Comp

    26402.42

    -138.93

    -0.52%

    S&P500 VIX

    15.20

    +0.69

    4.76%

    US 10-year yield

    4.720

    +0.048

    1.030%

    USD Index

    99.67

    +0.54

    0.54%

  • Aus Stocks

    31 August 2026   Updated : 20:12   AEDT

    Amcor (US)

    46.67

    +0.15

    0.32%

    Newmont (US)

    127.98

    -4.31

    -3.26%

    Rio Tinto (UK)

    7674.00

    -14.00

    -0.18%

    BHP Group (US)

    95.15

    -1.22

    -1.27%

    Rio Tinto (US)

    103.30

    -1.48

    -1.41%

    ResMed (US)

    240.33

    +4.57

    1.94%

    South32 (UK)

    277.00

    +1.00

    0.36%

    James Hardie (US)

    29.93

    +0.16

    0.54%

    Janus Henderson (US)

    51.95

    -0.02

    -0.04%

    Click item/line to change chart

  • Metals & Minerals

    31 August 2026   Updated : 07:10   AEDT

    Gold (oz)

    4454.08

    -147.09

    -3.20%

    Silver (oz)

    66.15

    -3.11

    -4.49%

    Copper (lb)

    6.5400

    -0.05

    -0.76%

    Aluminium (lb)

    1.4619

    0.00

    -0.17%

    Nickel (lb)

    7.6452

    +0.09

    1.14%

    Zinc (lb)

    1.8466

    -0.02

    -0.90%

    Copper (t)

    14414.16

    -110.20

    -0.76%

    Aluminium (t)

    3222.00

    -5.50

    -0.17%

    Nickel (t)

    16850.00

    +190.00

    1.14%

    Zinc (t)

    4070.00

    -37.00

    -0.90%

    Uranium (lb) weekly

    89.20

    -0.30

    -0.34%

    Iron Ore (t)

    95.84

    +0.16

    0.17%

  • Energy

    31 August 2026   Updated : 07:09   AEDT

    West Texas Crude

    83.44

    -0.08

    -0.10%

    Brent Crude

    88.29

    -1.25

    -1.40%

CALENDAR

Monday, 31 August 2026
NZ ANZ business confidence
AU 2Q Company profits, inventories
AU July Private Sector Credit
JP July Industrial prod'n
JP July Retail sales
CH Aug PMI
UK Public Holiday
US Aug Dallas Fed mfg
GE Aug CPI (prelim)
GE Aug CPI (prelim)
GE Aug CPI (prelim)
GE Aug CPI (prelim)
GE Aug CPI (prelim)

ALL WEATHER STOCKS

CodeCompanyPrice
CARCAR GROUP LIMITED

market icon up$27.65

REAREA GROUP LIMITED

market icon up$177.24

RMDRESMED INC

market icon up$33.04

TNETECHNOLOGY ONE LIMITED

market icon down$32.59

WOWWOOLWORTHS GROUP LIMITED

market icon up$40.31

WEEKLY PDF

Stories To Read From FNArena


WEEK 35
icon pdf

WEEK 34
icon pdf

WEEK 33
icon pdf

WEEK 32
icon pdf

WEEK 31
icon pdf

FNARENA TALKS

FNARENA WINDOWS

Window on HEALTH & NUTRITION

Chemist Warehouse A Winner For Sigma Healthcare

Sigma Healthcare’s FY26 result underscored the value of last year’s merger with the Chemist Warehouse pharmacy chain

1:31 PM


Window on REITS

Australian Listed Real Estate Tables – 31-08-2026

FNArena provides a weekly update of Australian listed real estate trusts (REIT) and property developers, current pricing yield and valuation data

10:45 AM


Window on INFRASTRUCTURE & UTILITIES

Dalrymple Bay’s Strong Yield Growth Outlook

Dalrymple Bay Infrastructure has appeal to investors seeking dependable and growing yield and defensive elements for their portfolio

Aug 27 2026


GEN AI

Book Excerpt: The AI Instinct

Excerpt from The AI Instinct: The Future of AI and Human Decision-Making by Rana Gujral

Aug 27 2026


FEATURE STORIES

Australian Banks, Bad Debts And The Budget

The March quarter turned sour for the banks and bad debt provisions were increased, ahead of a federal budget that will have significant impact on mortgage demand

May 20 2026